Utility of l-carnitine for preventing liver tumors derived from metabolic dysfunction–associated steatohepatitis
Schematic representation of how l-carnitine prevents the progression of MASH and the development of liver tumors. Insulin resistance, lipid peroxidation, and reactive oxygen species generation in MASH liver induce the expression of the stress-induced transcriptional factor EGR1. TGF-β1 accelerates the pathophysiology of MASH by acting as a positive feedback regulator between MASH and EGR1, which potentially activates the NEDD9/FAK/AKT oncogenic signaling pathway. l-carnitine could ameliorate EGR1-mediated NEDD9 expression by reducing ROS generation, improving lipid metabolism, and activating anti-inflammatory activity. Abbreviations: EGR1, early growth response 1; FAK, focal adhesion kinase; MASH, metabolic dysfunction–associated steatohepatitis; NEDD9, neural precursor cell expressed, developmentally downregulated protein 9; ROS, reactive oxygen species.